Study summary

The purpose of this study is to compare the effect of two anti-rejection therapy regimens on kidney function in kidney transplant recipients.

Additional Study Details

Phase
4
Product
Advagraf
Mycophenolate Mofetil
Sirolimus
Corticosteroids
Type
Interventional
Masking
None (Open Label)
Enrollment number
853
Show Additional Study Details

Study documents

Scientific Results Summary
Available Language(s): English
Plain Language Summary
Available Language(s): English

Get more information

Would you like more information about clinical trial sites that are recruiting participants for A study looking at kidney function in kidney transplant recipients who are taking anti-rejection medication including tacrolimus and with or without sirolimus.? Contact us by filling out your information to the right and we’ll respond to you.

  • A caregiver
  • A healthcare provider
  • A parent
  • A patient
  • A patient advocate
  • Algeria
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Belarus
  • Belgium
  • Bosnia And Herzegovina
  • Brazil
  • Bulgaria
  • Canada
  • Chile
  • China
  • Colombia
  • Croatia
  • Czech Republic
  • Denmark
  • Dominican Republic
  • Egypt
  • Estonia
  • Finland
  • Former Serbia and Montenegro
  • France
  • Georgia
  • Germany
  • Greece
  • Guatemala
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Jordan
  • Kazakhstan
  • Latvia
  • Lebanon
  • Lithuania
  • Macedonia
  • Malaysia
  • Mexico
  • Montenegro
  • Morocco
  • Netherlands
  • New Zealand
  • Norway
  • Panama
  • Peru
  • Philippines
  • Poland
  • Portugal
  • Puerto Rico
  • Republic of Korea
  • Republic of Moldova
  • Romania
  • Russian Federation
  • Saudi Arabia
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, Province of China
  • Thailand
  • Turkey
  • Ukraine
  • United Kingdom
  • United States
  • Vietnam

By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

    Locations

    Contact Us
    Contact Us
    Completed
    1548
    Leipzig, Germany, 04103
    Completed
    1140
    Vienna, Austria, 1090
    Completed
    5343
    Tainan, Taiwan, Province of China, 70403
    Completed
    3043
    Istanbul, Turkey, 34245
    Withdrawn
    3041
    Antalya, Turkey, 07059
    Completed
    1141
    Innsbruck, Austria, 6020
    Completed
    1545
    Hann.Munden, Germany, 34346
    Completed
    1740
    Brest Cedex 2, France, 29609
    Completed
    2641
    Poznan, Poland, 60-479
    Completed
    5245
    Busan, Republic of Korea, 614-735
    Completed
    1549
    Munchen, Germany, 81377
    Completed
    Site 1441
    Brno, Czech Republic, 656 91
    Completed
    1748
    Tours cedex 9, France, 37044
    Withdrawn
    1744
    Caen cedex 9, France, 14033
    Completed
    1643
    Santander, Spain, 39008
    Completed
    1547
    Kiel, Germany, 24105
    Completed
    3042
    Istanbul, Turkey, 07058
    Completed
    5244
    Seoul, Republic of Korea, 138-736
    Withdrawn
    2642
    Warsaw, Poland, 02-006
    Completed
    5342
    Taoyuan, Taiwan, Province of China, 33305
    Completed
    1240
    Liege 1, Belgium, 4000
    Completed
    2144
    Palermo, Italy, 90124
    Completed
    5042
    New Lambton, Australia, NSW 2305
    Completed
    1546
    Heidelberg, Germany, 69120
    Completed
    5241
    Seoul, Republic of Korea, 120-752
    Withdrawn
    2141
    Bologna, Italy, 40138
    Withdrawn
    3045
    Istanbul, Turkey, 06490
    Completed
    1742
    Clermont-Ferrand Cedex 1, France, 63003
    Completed
    1751
    Toulouse Cedex 9, France, 31059
    Completed
    3240
    Minsk, Belarus, 220116
    Withdrawn
    3540
    Vilnius, Lithuania, LT-08661
    Completed
    1142
    Linz, Austria, 4020
    Completed
    1550
    Munster, Germany, 48149
    Completed
    2640
    Lodz, Poland, 91-153
    Withdrawn
    3340
    Tartu, Estonia, 51014
    Completed
    5243
    Daegu, Republic of Korea, 700-721
    Completed
    2140
    Siena, Italy, 53100
    Completed
    1542
    Erlangen, Germany, 91054
    Completed
    1241
    Leuven, Belgium, 3000
    Completed
    5441
    Hong Kong, Hong Kong
    Completed
    1544
    Frankfurt, Germany, 60596
    Completed
    1641
    Barcelona, Spain, 08907
    Completed
    1749
    Paris Cedex 15, France, 75743
    Completed
    1752
    Amiens Cedex, France, 80054
    Completed
    2843
    Moscow, Russian Federation, 115446
    Completed
    1745
    Vandoeuvre Les Nancy Cedex, France, 54511
    Completed
    3044
    Istanbul, Turkey, 34732
    Completed
    1543
    Essen, Germany, 45147
    Completed
    5043
    Perth, Australia, WA 6009
    Completed
    2643
    Katowice, Poland, 40-027
    Completed
    2841
    Kemerovo, Russian Federation, 650066
    Completed
    2440
    Maastricht, Netherlands, 6229 HX
    Completed
    1746
    Creteil Cedex, France, 94010
    Completed
    1741
    Le Kremilin Bicetre Cedex, France, 94275
    Completed
    2842
    Omsk, Russian Federation, 644112
    Completed
    5242
    Seoul, Republic of Korea, 110-744
    Completed
    2840
    Vol'ginskiy, Russian Federation, 404120
    Withdrawn
    2142
    Pisa, Italy, 56124
    Completed
    1642
    Vizcaya, Spain, 48903
    Completed
    1640
    Alicante, Spain, 03010
    Completed
    1541
    Bochum, Germany, 44892
    Completed
    2143
    Roma, Italy, 00168
    Completed
    1540
    Hannover, Germany, 30625
    Completed
    1940
    Budapest, Hungary, 1082
    Withdrawn
    1743
    Paris cedex, France, 75010
    Completed
    1440
    Ostrava - Poruba, Czech Republic, 78 52
    Completed
    1750
    Dijon, France, 21000

    Frequently Asked Questions

    Are clinical trials only for people with advanced cancer?

    While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

    Will I have to stop my current treatment to participate in a clinical trial?

    Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

    Should I be worried about getting a placebo?

    In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

    Do I need a referral from my doctor to take part in a study?

    Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

    Explore More

    1

    What are clinical trials?

    2

    Why are Clinical Trials Important?

    3

    Why Participate in a Clinical Trial?